
Brian Steingo
Physician · Neuroscience Consultants Llp
Credentials: · · ·
History
- 2023–Present
Neuroscience Consultants Llp
- 1978–1982
Neurology
- 1967–1971
University
Research
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
Journal of Neurology · 2020 · First of 17 authors · Corresponding · 47 citations
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
Journal of Multiple Sclerosis · 2020 · 34 citations
BMC Neurology · 2014 · 34 citations
- AS
2 papers
- AB
2 papers
- DM
2 papers

2 papers
- DK
2 papers

2 papers
- KE
2 papers

2 papers
Clinical trials
- 2011–2012
Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis
Principal investigator · Completed · Phase 3
Acorda Therapeutics

